Description: Actosmet 15 mg/850 mg Tablets combine two active ingredients to manage type 2 diabetes mellitus effectively. This medication integrates the benefits of pioglitazone (15 mg) and metformin (850 mg), targeting improved insulin sensitivity and enhanced glycemic control. Designed for use in combination with diet and exercise, Actosmet helps to better manage blood glucose levels.
Ingredients:
-
Active Ingredients:
- Pioglitazone Hydrochloride 15 mg
- Metformin Hydrochloride 850 mg
-
Other Ingredients: [List any additional ingredients such as excipients, binders, or colorants, if applicable.]
Usage Instructions:
-
Dosage: Take one tablet twice daily, or as directed by your healthcare provider.
-
Frequency: Typically twice daily, with meals to minimize gastrointestinal side effects.
-
Special Considerations: Swallow the tablet whole with a glass of water. Do not crush or chew. Follow your healthcare provider’s instructions regarding dosage and dietary adjustments.
Benefits:
- Combines two mechanisms of action for improved blood glucose control.
- Enhances insulin sensitivity and reduces blood sugar levels.
- Provides a comprehensive approach to managing type 2 diabetes when combined with diet and exercise.
Precautions:
-
Contraindications: Not recommended for individuals with a known allergy to pioglitazone, metformin, or any other components. Avoid use in patients with severe renal impairment or liver disease.
-
Side Effects: Possible side effects include gastrointestinal issues such as nausea, diarrhea, and abdominal discomfort. More serious side effects could include lactic acidosis or heart failure. Contact your healthcare provider if you experience severe symptoms.
-
Interactions: Inform your doctor of all other medications and supplements you are taking to avoid potential interactions. Use caution with other drugs affecting blood glucose levels.
Storage Instructions:
- Store at room temperature, between 15°C and 25°C (59°F and 77°F).
- Keep in a dry place away from direct sunlight and moisture.
- Keep out of reach of children.
Manufacturer: Jazeera Pharmaceutical Industries (JPI)
